When Karen first went in for an MRI because of chronic headaches, cancer wasn’t even on her radar.

The scan found something unusual in her neck. A biopsy confirmed lymphoma. Then doctors ordered additional imaging to see whether the lymphoma had spread. That’s when they found something else. Suspicious spots on her liver.

A second biopsy revealed stage 4 melanoma that had metastasized from a melanoma spot on her back. By the time doctors discovered it, there were at least 20 lesions on her liver.

What followed became a whirlwind of hospital visits, sleepless nights, research, immunotherapy, supplements, difficult conversations with doctors, and a determination to leave no stone unturned.

Recently, Karen and her husband Jeff shared their experience publicly in a video interview discussing the path they took, including conventional treatment, repurposed medications like ivermectin and fenbendazole, supplements, cannabis products, prayer, and integrative support resources.

Their story has started gaining attention because, according to the interview, Karen’s follow-up PET scan just three months later reportedly showed no remaining melanoma lesions on her liver.

“I Wanted Every Option Available”

Karen’s oncologists recommended immunotherapy immediately.

She underwent treatment using two immunotherapy drugs after having a port installed. According to the interview, she completed 11 total treatments.

At the same time, Jeff says they began researching additional approaches outside standard oncology protocols.

“We started immediately doing fenbendazole, ivermectin,” Jeff explained in the interview, referencing the Joe Tippens protocol.

Jeff, a registered nurse, described spending countless nights researching supplements, alternative therapies, cannabis products, and patient stories while trying to support his wife through two separate cancer diagnoses happening at once.

He repeatedly emphasized one thing throughout the conversation. They were not rejecting conventional medicine.

They wanted more than one strategy.

“I wanted every option available,” he said.

That line probably resonates with many cancer patients and families.

Because when people hear “watch and wait,” “there’s nothing else,” or “just trust the process,” it can leave them feeling powerless. Especially when the disease feels urgent.

The Growing Interest in Repurposed Drugs

Over the past several years, drugs like ivermectin and fenbendazole have become increasingly discussed in alternative cancer communities online.

Supporters point to laboratory studies, anecdotal reports, and patient stories suggesting these medications may affect cancer pathways, inflammation, metabolism, or immune response. Critics argue the evidence remains limited, incomplete, or largely preclinical.

That tension showed up throughout Karen and Jeff’s interview.

Jeff openly acknowledged their oncologists were uncomfortable with some of the protocols they pursued alongside immunotherapy. One doctor, according to the interview, warned Karen she likely had six months to live and criticized their use of alternative therapies.

Still, they moved forward.

Not recklessly, at least in their minds. Intentionally.

Jeff repeatedly says they viewed their approach as complementary rather than either-or. He believes the combination of therapies, supplements, lifestyle changes, and immunotherapy all worked together.

That distinction matters.

A lot of patients exploring integrative or alternative approaches are not necessarily abandoning oncology. Many are trying to combine conventional care with additional therapies they believe could support the body during treatment.

Immunotherapy Likely Played a Major Role

One thing worth stating clearly is this.

Immunotherapy has changed outcomes for some advanced melanoma patients in ways that would have sounded almost impossible twenty years ago.

Drugs like Opdivo (nivolumab) and Yervoy (ipilimumab) have produced long-term remissions in some stage 4 melanoma cases. Karen’s rapid response timeline aligns with what oncologists sometimes see in strong immunotherapy responders.

Even Jeff acknowledged throughout the interview that the conventional treatments appeared to be working.

That’s important context because stories involving alternative therapies can quickly become oversimplified online.

There’s a difference between saying:

“Here’s what this couple chose to do.”

…and claiming:

“This protocol cures cancer.”

Those are not the same thing.

Karen and Jeff themselves repeatedly avoided making definitive claims. In fact, Jeff directly stated:

“I can’t say definitively 100% that it was responsible for everything that we see here today.”

That honesty gives the conversation more credibility, not less.

The Emotional Side of Cancer Nobody Talks About Enough

One of the strongest parts of the interview had nothing to do with supplements or drugs.

It was the exhaustion.

The fear.

The desperation of trying to make the right decisions while watching someone you love fight for their life.

Jeff described staying up night after night researching treatments, printing studies, organizing notebooks, tracking lab work, and trying to make sense of endless information.

Karen talked about chemo brain, fatigue, itching, digestive issues, and the emotional weight of the process itself.

That part often gets lost online.

People sometimes discuss cancer protocols like they’re comparing workout plans or productivity apps.

But this is life-and-death decision making happening under enormous pressure.

Families are scared. Patients are scared. Doctors are trying to balance evidence, liability, risk, and outcomes. Everyone is operating inside uncertainty.

“It’s Your Life. It’s Your Body.”

Toward the end of the interview, Jeff made a statement that reflects a growing mindset among many patients navigating serious illness.

“It’s your life. It’s your body.”

Whether people agree with every decision they made or not, that sentence captures something important happening in healthcare right now.

Patients are asking more questions.

They are researching clinical trials, integrative therapies, nutrition, metabolic health, supplements, repurposed medications, and lifestyle interventions. They are comparing experiences online. They are trying to become active participants in their care instead of passive observers.

Sometimes that leads people toward good information.

Sometimes toward questionable information.

Usually, it’s a mix of both, which is why discernment matters so much.

Why Stories Like This Matter

At Journey to Wellness, we believe stories matter because they expand conversations.

Not every therapy works for every patient. Not every anecdote becomes scientific proof. Not every experimental or alternative approach will hold up under rigorous research.

But patient experiences still deserve thoughtful discussion.

Especially when they raise important questions about integrative care, patient autonomy, emerging therapies, hope, and the need for individualized approaches to cancer treatment.

Karen’s story is not presented here as medical advice or a guaranteed outcome.

It’s one family’s account of what they chose to pursue during an aggressive cancer battle. A story involving immunotherapy, extensive research, supplements, repurposed medications, prayer, community support, and persistence.

And for many readers walking through cancer themselves, sometimes hearing that someone kept fighting matters more than anything else.

Watch the full interview here: From Stage 4 to Clear Scans in 90 Days

The post From Stage 4 Melanoma to Clear Scans in 90 Days first appeared on Journey to Wellness.